Health Condition 1: A00-B99- Certain infectious and parasitic diseases Health Condition 2: A90- Dengue fever [classical dengue]
Conditions
Interventions
Intervention1: Vitamin E and vitamin C: Patients who receive vitamin e and vitamin c supplementation for 5 days
Control Intervention1: Patients: Patients who receive standard treatment only
Sponsors
Srikanth
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children between the ages of 5-18 years and who fulfilled the clinical criteria of dengue fever (fever and 2 of the symptoms: headache, retro-orbital pain, myalgia, arthralgia, bone pain and hemorrhagic manifestations) with diagnosed NS1AG positive or dengue IgG anspd IgM positive 2. Patients of dengue fever (as per WHO criteria) with thrombocytopenia ( platelet count < 1.5lakhs)
Exclusion criteria
Exclusion criteria: 1. Patients of dengue fever with platelet counts > 1.5lakhs 2. Patients who already started on vitamin E and vitamin C supplementation prior to admission 3. Patients of dengue fever with severe thrombocytopenia requiring platelet transfusion. 4. Patients of dengue fever with severe GI bleeding manifestations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of vitamin e and vitamin c supplementation on thrombocytopenia in dengue feverTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of vitamin e and vitamin c supplementation on thrombocytopenia in dengue feverTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Srikanth Bhuvanagiri
Jawaharlal nehru medical college
Outcome results
None listed